Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Venlafaxine for Depression in Alzheimer's Disease

NCT01609348 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01609348
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609348 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Venlafaxine for Depression in Alzheimer's Disease
Lead sponsor
Johns Hopkins University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
January 31, 2017
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, depression